Poseida Therapeutics, Inc.
PSTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$123,430 | -$64,002 | -$124,974 | -$129,775 |
| Dep. & Amort. | $5,614 | $5,172 | $4,552 | $2,586 |
| Deferred Tax | $0 | $0 | -$19,632 | $213 |
| Stock-Based Comp. | $23,134 | $18,926 | $16,704 | $7,220 |
| Change in WC | $14,081 | $13,715 | $20,168 | $5,623 |
| Other Non-Cash | -$11,566 | -$583 | $639 | $805 |
| Operating Cash Flow | -$92,167 | -$26,772 | -$102,543 | -$113,328 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,066 | -$3,924 | -$2,634 | -$16,908 |
| Net Acquisitions | $0 | $12 | $18 | $187,523 |
| Inv. Purchases | -$237,800 | -$294,422 | -$18 | -$295,023 |
| Inv. Sales/Matur. | $280,000 | $95,000 | $225,000 | $107,500 |
| Other Inv. Act. | $0 | -$199,410 | $18 | -$187,523 |
| Investing Cash Flow | $39,134 | -$203,334 | $222,384 | -$204,431 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $30,000 | $0 | $0 |
| Stock Issued | $15,345 | $75,299 | $2,518 | $205,743 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $782 | -$140 | $2,518 | $108,198 |
| Financing Cash Flow | $16,127 | $105,159 | $2,518 | $313,941 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$36,906 | -$124,947 | $122,359 | -$3,818 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81,378 | $206,325 | $83,966 | $87,784 |
| End Cash | $44,472 | $81,378 | $206,325 | $83,966 |
| Free Cash Flow | -$95,233 | -$30,696 | -$105,177 | -$130,236 |